Lexology January 20, 2026
Explore some of the ways in which consumer protection regulators tackled health care issues in 2025, from GLP-1 weight loss drugs to Artificial intelligence (AI) oversight and pricing transparency. Learn what enforcement trends mean for health care companies in 2026.
KEY POINTS:
- GLP-1 enforcement heats up. State attorneys general and the Federal Trade Commission (FTC) cracked down on misleading marketing and unapproved GLP-1 weight loss products, signaling ongoing scrutiny of this booming market.
- AI oversight expands at the state level. States are applying existing consumer protection laws and introducing new legislation to address risks posed by AI in health care. Federal guidance remains uncertain.
- Pricing practices under the microscope. State and federal laws targeting “junk fees” and algorithmic pricing...







